Promotion of IL8, IL10, TNFα and TNFβ production by EBV infection

Leukemia Research

Volumn 20, Issue 8, 1996, Pages 633-636

  Klein, Sigrid C ^a,b   Kube, Dieter ^a   Abts, Harry ^a   Diehl, Volker ^a   Tesch, Hans ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Burkitt's lymphoma; Cytokine production; EBV

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; VIRUS INFECTION;

EID: 0030221688     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00029-X     Document Type: Article

References (21)

1. 1. Epstein M. A. & Achong B. G. (1979) Relationship of the virus to Burkitt's lymphoma. In The Epstein-Barr Virus (Epstein M. A. & Achong B. G., Eds), p. 321. Springer, Berlin.
2. 2. Lenoir G. M., Philip P. & Sohier R. (1984) Burkitt's type lymphoma: EBV association and cytogenetic markers in cases from various geographic origins. In Environmental Influences in the Pathogenesis of Leukaemias and Lymphomas (Magrath I., O'Conor G. T. & Ramot B., Eds), p. 283. Raven Press, New York.
3. 3. Heller M., Dambaugh T. & Kieff E. (1981) Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. J. Virol. 38, 632.
4. 4. Jeang K. T. & Hayward S. D. (1983) Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcript. J. Virol. 48, 135.
5. 5. Bornkamm G. W., Delius H., Zimber U., Hudewentz J. & Epstein M. A. (1980) Comparison of Epstein-Barr virus strains of different origin by analysis of viral DNAs. J. Virol. 35, 603.
6. 6. Calender A., Billaud M., Aubry J. P., Banchereau J., Vuillaume M. & Lenoir G. M. (1987) Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. natn. Acad. Sci. U.S.A. 84, 8060.
7. 7. Fahraeus R., Jansson A., Ricksten A., Sjoblom A. & Rymo L. (1990) Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. natn. Acad. Sci. U.S.A. 87, 7390.
8. 8. Wang F., Tsang S. F., Kurilla M. G., Cohen J. I. & Kieff E. (1990) Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64, 3407.
9. 9. Hsu S. M., Waldron J. W., Hsu P. L. & Hough A. J. (1993) Cytokines in malignant lymphomas. Human Pathol. 24, 1040.
10. 10. Nakagomi H., Dolcetti R., Bejarano M. T., Pisa P., Kiessling R. & Masucci M. G. (1994) The Epstein-Barr virus latent membrane protein-1 (LMP-1) induces interleukin-10 production in Burkitt lymphoma lines. Int. J. Cancer 57, 240.
11. 11. Lenoir G. M., Preud'homme J. L., Bernheim A. & Berger R. (1982) Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 298, 474.
12. 12. Lenoir G. M., Vuillaume M. & Bonnardel C. (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. In Burkitt's Lymphoma, A Human Cancer Model (Lenoir G. M., O'Connor G. T. & Oeweny C. L. M., Eds). IARC Scientific Publications No. 60, Lyon.
13. 13. Chomczynski P. & Sacci N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Annal. Biochem. 162, 156.
14. 14. Platzer C., Ode-Hakim S., Reinke P., Döcke W. D. & Volk H. D. (1994) Quantitative PCR analysis of cytokine transcription pattern in PBMC after anti-CD3 therapy using two novel multispecific competitor fragments. Transplantation 58, 264.
15. 15. Zimber-Strobl U., Kremmer E., Grässer F., Marshall G., Laux G. & Bornkamm G. W. (1993) The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12, 167.
16. 16. Baichwal V. R. & Sugden B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2, 461.
17. 17. Wang D., Liebowitz D. & Kieff E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831.
18. 18. Wang D., Liebowitz D. & Kieff E. (1988) The truncated form of the Epstein-Barr virus latent infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 62, 2337.
19. 19. Gibbons D. L., Rowe M., Cope A. P., Feldmann M. & Brennan F. M. (1994) Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur. J. Immunol. 24, 1879.
20. 20. Birkenbach M., Josefsen K., Yalamanchili R., Lenoir L. & Kieff E. (1993) Epstein-Barr Virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67, 2209.
21. 21. Kube D., Platzer C., Knethen A. von, Straub H., Bohlen H., Hafner M. & Tesch H. (1995) Isolation and characterization of the human IL10 promoter in Burkitt's lymphoma. Cytokine 7, 1.